Literature DB >> 30114530

The role of nitrite in muscle function, susceptibility to contraction injury, and fatigability in sickle cell mice.

Li Wang1, Luis E F Almeida2, Sayuri Kamimura2, Jack H van der Meulen3, Kanneboyina Nagaraju3, Martha Quezado4, Paul Wakim5, Zenaide M N Quezado6.   

Abstract

Sickle cell disease (SCD) patients can have limited exercise capacity and muscle dysfunction characterized by decreased force, atrophy, microvascular abnormalities, fiber distribution changes, and skeletal muscle energetics abnormalities. Growing evidence suggests that in SCD there is alteration in nitric oxide (NO) availability/signaling and that nitrate/nitrite can serve as a NO reservoir and enhance muscle performance. Here, we examined effects of nitrite on muscle strength, exercise capacity, and on contractile properties of fast-(extensor digitorum longus, EDL) and slow-twitch (soleus) muscles in SCD mice. Compared to controls, homozygotes (sickling) had decreased grip strength, impaired wheel running performance, and decreased muscle mass of fast-twitch, but not slow-twitch muscle. Nitrite treatment yielded increases in nitrite plasma levels in controls, heterozygotes, and homozygotes but decreases in muscle nitrite levels in heterozygotes and homozygotes. Regardless of genotype, nitrite yielded increases in grip strength, which were coupled with increases in specific force in EDL, but not in soleus muscle. Further, nitrite increased EDL, but not soleus, fatigability in all genotypes. Conversely, in controls, nitrite decreased, whereas in homozygotes, it increased EDL susceptibility to contraction-induced injury. Interestingly, nitrite yielded no changes in distances ran on the running wheel. These differential effects of nitrite in fast- and slow-twitch muscles suggest that its ergogenic effects would be observed in high-intensity/short exercises as found with grip force increases but no changes on wheel running distances. Further, the differential effects of nitrite in homozygotes and control animals suggests that sickling mice, which have altered NO availability/signaling, handle nitrite differently than do control animals. Published by Elsevier Inc.

Entities:  

Keywords:  Contractility; Fatigue; Function; Muscle; Pain; Strength

Mesh:

Substances:

Year:  2018        PMID: 30114530      PMCID: PMC6186197          DOI: 10.1016/j.niox.2018.08.005

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  75 in total

Review 1.  Pulmonary hypertension and nitric oxide depletion in sickle cell disease.

Authors:  H Franklin Bunn; David G Nathan; George J Dover; Robert P Hebbel; Orah S Platt; Wendell F Rosse; Russell E Ware
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

2.  Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study.

Authors:  Katherine E Lansley; Paul G Winyard; Jonathan Fulford; Anni Vanhatalo; Stephen J Bailey; Jamie R Blackwell; Fred J DiMenna; Mark Gilchrist; Nigel Benjamin; Andrew M Jones
Journal:  J Appl Physiol (1985)       Date:  2010-11-11

3.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

Review 4.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

5.  Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle.

Authors:  Justin M Percival; Kendra N E Anderson; Paul Huang; Marvin E Adams; Stanley C Froehner
Journal:  J Clin Invest       Date:  2010-03       Impact factor: 14.808

6.  Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Authors:  Mark T Gladwin; Alan N Schechter; Frederick P Ognibene; Wynona A Coles; Christopher D Reiter; William H Schenke; Gyorgy Csako; Myron A Waclawiw; Julio A Panza; Richard O Cannon
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

7.  Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.

Authors:  Suborno M Ghosh; Vikas Kapil; Isabel Fuentes-Calvo; Kristen J Bubb; Vanessa Pearl; Alexandra B Milsom; Rayomand Khambata; Sheiva Maleki-Toyserkani; Mubeen Yousuf; Nigel Benjamin; Andrew J Webb; Mark J Caulfield; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

Review 8.  An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy.

Authors:  Christopher D Reiter; Mark T Gladwin
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

9.  Isoform-specific differences in the nitrite reductase activity of nitric oxide synthases under hypoxia.

Authors:  Ivan Mikula; Suzanne Durocher; Pavel Martasek; Bulent Mutus; Anny Slama-Schwok
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

10.  Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage.

Authors:  Andrew Webb; Richard Bond; Peter McLean; Rakesh Uppal; Nigel Benjamin; Amrita Ahluwalia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

View more
  5 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

2.  Sickle cell disease subjects and mouse models have elevated nitrite and cGMP levels in blood compartments.

Authors:  Luis E F Almeida; Sayuri Kamimura; Celia M de Souza Batista; Nicholas Spornick; Margaret Y Nettleton; Elizabeth Walek; Meghann L Smith; Julia C Finkel; Deepika S Darbari; Paul Wakim; Zenaide M N Quezado
Journal:  Nitric Oxide       Date:  2019-11-02       Impact factor: 4.427

3.  Locomotor mal-performance and gait adaptability deficits in sickle cell mice are associated with vascular and white matter abnormalities and oxidative stress in cerebellum.

Authors:  Luis E F Almeida; Li Wang; Sayuri Kamimura; Patricia M Zerfas; Meghann L Smith; Osorio L Abath Neto; Ticiana Vale; Martha M Quezado; Iren Horkayne-Szakaly; Paul Wakim; Zenaide M N Quezado
Journal:  Brain Res       Date:  2020-06-10       Impact factor: 3.252

Review 4.  Nitric oxide and sickle cell disease-Is there a painful connection?

Authors:  Lillian Hallmark; Luis Ef Almeida; Sayuri Kamimura; Meghann Smith; Zenaide Mn Quezado
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-06

5.  Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities.

Authors:  Alfia Khaibullina; Luis E F Almeida; Sayuri Kamimura; Patricia M Zerfas; Meghann L Smith; Sebastian Vogel; Paul Wakim; Olavo M Vasconcelos; Martha M Quezado; Iren Horkayne-Szakaly; Zenaide M N Quezado
Journal:  Blood Cells Mol Dis       Date:  2020-09-04       Impact factor: 3.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.